Earkart has informed that the Board of Directors of the Company in their meeting held on 29 May 2026, has approved the incorporation of a wholly owned subsidiary by the name 'Earkart Pharmaceuticals Private Limited' and 'Earkart Healthcare Services‘.
The above information is a part of company’s filings submitted to BSE.